Inloggad som:
ROCKnrol-1
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
ROCKnrol-1
A randomized, double-blind, multicenter, phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD) [Protocol number: EFC17757]
A randomized, double-blind, multicenter, phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD) [Protocol number: EFC17757]
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: Mirella Wahl (2024-10-08)